St-Petersburg Hematological Centre Experience on the Use of BMT in Relapsed/Refractory Malignant Lymphomas: Brentuximab Vedotin is Safe and Effective as a Bridge Therapy and for Relapses after allo-HSC
Comments 0
Login to view comments.
Click here to Login
